ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best healthcare penny stocks to buy now. On September 8, 2025, ImmunityBio Inc.

The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.

The ACIP meeting, shaped entirely by RFK Jr.'s political appointees, exposed a shift from evidence-driven public health ...

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibo ...

Rodger offers close attention to the somewhat impossible act of prognostication that is ship design over these 130 years.

As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect ...

Daiichi Sankyo Company, Limited ( OTCPK:DSNKY) Discusses on WCLC 2025 Highlights (Transcript) Kentaro Asakura - Corporate Officer, Head of Corporate Communications Deptt, Global Corporate Planning & ...

Sometimes cars make it all the way to production possibility before being snuffed out at the last minute. Here are 44 of the ...

HDT Bio Corporation, a U.S.-based clinical-stage biotechnology company advancing immune-enhancing solutions for global health, biodefense, and oncology, today announced that the U.S. Food and Drug ...

Brett James wrote a slew of country number ones, including “Jesus, Take the Wheel” and “When the Sun Goes Down.” ...

The NF-kB inhibitors market is poised for growth driven by the increasing prevalence of cancer, autoimmune, and inflammatory diseases where NF-kB plays a central role. Additionally, the expected ...

New investments focus on biotherapeutics, RNA medicines, cell therapies and policy innovation to prepare for the future ...